Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients.

Peters L, Mocroft A, Soriano V, Rockstroh J, Rauch A, Karlsson A, Knysz B, Pradier C, Zilmer K, Lundgren JD; for EuroSIDA in EuroCoord.

PLoS One. 2013 May 27;8(5):e64283. doi: 10.1371/journal.pone.0064283. Print 2013.

2.

Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study.

SMART Study Group, Peters L, Neuhaus J, Mocroft A, Soriano V, Rockstroh J, Dore G, Puoti M, Tedaldi E, Clotet B, Kupfer B, Lundgren JD, Klein MB.

Antivir Ther. 2011;16(5):667-75. doi: 10.3851/IMP1815.

3.

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study.

Peters L, Neuhaus J, Duprez D, Neaton JD, Tracy R, Klein MB, Mocroft A, Rockstroh J, Dore G, Lundgren JD; INSIGHT SMART Study Group.

J Clin Virol. 2014 Jul;60(3):295-300. doi: 10.1016/j.jcv.2014.03.017. Epub 2014 Apr 8.

PMID:
24793968
4.

Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?

Resino S, Bellón JM, Asensio C, Micheloud D, Miralles P, Vargas A, Catalán P, López JC, Alvarez E, Cosin J, Lorente R, Muñoz-Fernández MA, Berenguer J.

BMC Infect Dis. 2010 Aug 19;10:244. doi: 10.1186/1471-2334-10-244.

5.

Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis.

Grint D, Peters L, Rockstroh JK, de Wit S, Mitsura VM, Knysz B, Pedersen C, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord.

AIDS. 2014 Feb 20;28(4):577-87. doi: 10.1097/QAD.0000000000000069.

PMID:
24468998
6.

Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH.

J Hepatol. 2005 Jul;43(1):78-84. Epub 2005 Apr 25.

PMID:
15894397
7.

Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.

Parsian H, Rahimipour A, Nouri M, Somi MH, Qujeq D, Fard MK, Agcheli K.

J Gastrointestin Liver Dis. 2010 Jun;19(2):169-74. Retraction in: Acalovschi M. J Gastrointestin Liver Dis. 2012 Mar;21(1):118.

8.

Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis.

Merchante N, Rivero-Juárez A, Téllez F, Merino D, José Ríos-Villegas M, Márquez-Solero M, Omar M, Macías J, Camacho A, Pérez-Pérez M, Gómez-Mateos J, Rivero A, Antonio Pineda J; Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).

Hepatology. 2012 Jul;56(1):228-38. doi: 10.1002/hep.25616. Epub 2012 Jun 6.

PMID:
22278746
9.

Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients.

Larrousse M, Laguno M, Segarra M, De Lazzari E, Martinez E, Blanco JL, León A, Deulofeu R, Miquel R, Milinkovic A, Lonca M, Miró JM, Biglia A, Murillas J, Gatell JM, Mallolas J.

J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):304-11.

PMID:
18172937
10.

Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.

Aldámiz-Echevarría T, Berenguer J, Miralles P, Jiménez-Sousa MA, Carrero A, Pineda-Tenor D, Díez C, Tejerina F, Pérez-Latorre L, Bellón JM, Resino S.

PLoS One. 2016 Feb 5;11(2):e0148537. doi: 10.1371/journal.pone.0148537. eCollection 2016.

11.

YKL-40 and hyaluronic acid (HA) as noninvasive markers of liver fibrosis in kidney transplant patients with HCV chronic infection.

Schiavon LL, Carvalho-Filho RJ, Narciso-Schiavon JL, Medina-Pestana JO, Lanzoni VP, Ferraz ML, Silva AE.

Scand J Gastroenterol. 2010 May;45(5):615-22. doi: 10.3109/00365521003637203.

PMID:
20163287
12.

Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.

Hartley JL, Brown RM, Tybulewicz A, Hayes P, Wilson DC, Gillett P, McKiernan P.

J Pediatr Gastroenterol Nutr. 2006 Aug;43(2):217-21.

PMID:
16877988
13.

Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.

Sanvisens A, Serra I, Tural C, Tor J, Ojanguren I, Barluenga E, Rey-Joly C, Clotet B, Muga R.

J Viral Hepat. 2009 Jul;16(7):513-8. doi: 10.1111/j.1365-2893.2009.01103.x. Epub 2009 Feb 5.

PMID:
19200132
14.

Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.

Yilmaz S, Bayan K, Tüzün Y, Dursun M, Kaplan A, Ozmen S, Canoruç F, Akkuş Z.

Int J Clin Pract. 2007 Mar;61(3):438-43.

PMID:
17313611
15.

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.

Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, Pockros PJ, Blatt LM, Conrad A, McHutchison JG.

J Gastroenterol Hepatol. 2003 Mar;18(3):253-7.

PMID:
12603524
16.

Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major.

El-Shabrawi MH, Zein El Abedin MY, Omar N, Kamal NM, Elmakarem SA, Khattab S, El-Sayed HM, El-Hennawy A, Ali AS.

Arab J Gastroenterol. 2012 Jun;13(2):45-8. doi: 10.1016/j.ajg.2012.06.006. Epub 2012 Jul 11.

PMID:
22980590
17.

Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy.

Fernández-Montero JV, Barreiro P, Vispo E, Labarga P, Sánchez-Parra C, Soriano V.

AIDS. 2013 Apr 24;27(7):1129-34. doi: 10.1097/QAD.0b013e32835e063f.

PMID:
23276803
18.

Cytokeratin-18 and hyaluronic acid levels predict liver fibrosis in children with non-alcoholic fatty liver disease.

Lebensztejn DM, Wierzbicka A, Socha P, Pronicki M, Skiba E, Werpachowska I, Kaczmarski M.

Acta Biochim Pol. 2011;58(4):563-6. Epub 2011 Dec 3.

19.

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.

McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ.

J Gastroenterol Hepatol. 2000 Aug;15(8):945-51.

PMID:
11022838
20.

Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.

Boulware DR, Hullsiek KH, Puronen CE, Rupert A, Baker JV, French MA, Bohjanen PR, Novak RM, Neaton JD, Sereti I; INSIGHT Study Group.

J Infect Dis. 2011 Jun 1;203(11):1637-46. doi: 10.1093/infdis/jir134.

Items per page

Supplemental Content

Write to the Help Desk